Multiprofile Hospital of Active Treatment - Dobrich AD

Dobrich 9300

0 studies enrolling now · 1 studies all time

What they study most

HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer

Studies at this site

• A Study of PF-06873600 in People With Cancer — Stopped early